Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial

Published:2016-04 Issue:4 Volume:3 Page:e158-e165
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Gallant Joel E,Daar Eric S,Raffi François,Brinson Cynthia,Ruane Peter,DeJesus Edwin,Johnson Margaret,Clumeck Nathan,Osiyemi Olayemi,Ward Doug,Morales-Ramirez Javier,Yan Mingjin,Abram Michael E,Plummer Andrew,Cheng Andrew K,Rhee Martin S

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference17 articles.

1. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

2. Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults;Markowitz;J Antimicrob Chemother,2014

3. Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults;Ruane;J Acquir Immune Defic Syndr,2013

4. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials;Sax;Lancet,2015

5. Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study;Sax;J Acquir Immune Defic Syndr,2014

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Comparative evaluation of adverse drug reactions for tenofovir alafenamide and tenofovir disoproxil fumarate using the FAERS Database: a disproportionality analysis;Expert Opinion on Drug Safety;2024-08-19

3. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17

4. Epidemiología, tratamiento y pronóstico de la infección VIH en 2024: revisión práctica;Medicina Clínica;2024-06

5. Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review;Medicina Clínica (English Edition);2024-06